Key points are not available for this paper at this time.
Clinical guidelines support the use of fixed-dose combinations (FDC) for prevention of cardiovascular disease. Implementation of FDC into clinical care remains challenging, and current population-based data are scarce.
Götzinger et al. (Tue,) studied this question.